1H-Benzimidazole-1-propanoic acid, 5,6-dimethyl- - Names and Identifiers
1H-Benzimidazole-1-propanoic acid, 5,6-dimethyl- - Physico-chemical Properties
Molecular Formula | C12H14N2O2
|
Molar Mass | 218.25 |
Storage Condition | Room Temprature |
Sensitive | Irritant |
MDL | MFCD02749820 |
1H-Benzimidazole-1-propanoic acid, 5,6-dimethyl- - Risk and Safety
Hazard Symbols | Xi - Irritant
|
Hazard Class | IRRITANT |
1H-Benzimidazole-1-propanoic acid, 5,6-dimethyl- - Introduction
3-(5,6-Dimethylbenzimidazol-l-yl)-propionic acid (3-(5, 5-yl)-propionic acid) is an organic compound. It has the following properties:
1. appearance: mostly white crystal or crystalline powder.
2. molecular formula: C13H14N2O2.
3. Relative molecular mass: 230.26g/mol.
4. melting point: about 160-162 ℃.
5. Solubility: Soluble in alcohol, ketone and organic solvent, slightly soluble in water.
3-(5,6-dimethylbenzimidazole-1-yl)-propionic acid is commonly used in drug research, the main uses are as follows:
1. Antibacterial activity: It has certain antibacterial and antifungal activity and can be used to develop new antibiotics and antifungal drugs.
2. Anti-tumor activity: It has certain anti-tumor activity and has the potential to become a candidate molecule for anti-cancer drugs.
The preparation method of 3-(5,6-dimethylbenzimidazole-1-yl)-propionic acid mainly includes the following steps:
1. An appropriate amount of 5,6-dimethylbenzimidazole -1-amine is reacted with acetone under acidic conditions to obtain an intermediate product.
2. The intermediate product is then reacted with chloroformic acid under alkaline conditions to obtain the final product.
With regard to safety information, there are limited data on the toxicity and safety of 3-(5,6-dimethylbenzimidazol-1-yl)-propionic acid due to the lack of specific information or research reports available. In all cases, when using this compound or potentially related compounds, appropriate safe operating standards and operating procedures should be followed to ensure appropriate personal protective measures.
Last Update:2024-04-09 21:21:28